Effects of dietary protein sources and their adequacy on muscle function, body composition, and risk of sarcopenic obesity in South Korean populations: A cross-sectional study

DOI: https://doi.org/10.21203/rs.3.rs-2037581/v1

Abstract

Background

Dietary protein sources and protein adequacy are crucial modulators of muscle quality and body composition. We investigated the association between dietary protein sources (and their adequacy) and prevalence of sarcopenic obesity (SO) in South Korean populations according to weight status.

Methods

The participants (n = 1,967) were classified into SO, obese, sarcopenia, and normal groups. A cross-sectional survey was conducted using the KS-15 questionnaire, short-form Food Frequency Questionnaire, and anthropometric measurements.

Results

Percentage of body fat (male: 28.43 ± 0.61%; female: 39.95 ± 0.36%) was significantly high, while appendicular skeletal muscle (ASM; male: 40.30 ± 0.36%, female: 32.47 ± 0.20%) was low in the SO and OB groups. Beef and pork consumption was negatively associated with ASM (%) but positively associated with body fat (kg and %) in the normal group. Among the people with excessive protein intake, the lowest quintile (Q1: 5.7 g/day) of beans and tofu consumption showed a 2.4-fold increase in the risk of developing SO (adjusted odds ratio: 2.41, confidence interval: 1.07–7.80), when compared with the highest quintile (Q5: 60.1 g/day). Similarly, with beans and tofu consumption, there was a 2.5-fold higher risk of developing sarcopenia in participants who had < 5.7 g/day intake in the excessive protein intake individuals.

Conclusions

Daily poultry and egg intake was positively linked with muscle function in the participants with sarcopenia, while red meat showed a negative effect on imbalanced body composition with increased fat mass (kg and %) and decreased ASM (%) in participants with normal weight. Furthermore, lower intake of healthy protein foods, such as beans and tofu or poultry and eggs, was strongly associated with SO prevalence in people who consumed excessive daily dietary protein.

Background

Sarcopenic obesity (SO) is a double-burden condition characterized by a decline in muscular quality and excess body fat mass (1). SO is caused not only by aging but also by non-communicable diseases, such as cardiovascular diseases (CVDs), metabolic syndrome (MetS), and obesity (2). Obesity is a risk factor for chronic diseases, including type 2 diabetes mellitus (T2DM), CVDs, and all-cause mortality (35). The coexistence of excess adiposity and loss of muscle mass negatively affects the prognosis of obese individuals (1).

As a multifactorial disease, SO is driven by metabolic health status and lifestyle factors, such as diet and physical activity (PA) (6). Unhealthy lifestyles, including smoking, alcohol consumption, lack of PA, and adherence to an unhealthy diet, showed strong associations with the development of cardiometabolic diseases in a multinational prospective cohort study (7). Korean medicine (KM) type (8) has a genetic predisposition for abdominal obesity (9), insulin resistance (10), metabolic syndrome (11, 12), and inflammatory status (13) in various South Korean population-based studies.

Body composition is a reliable predictor of good health status and is evaluated by fat-free mass, fat mass, and bone mineral density (14). Body composition disorder is the development of a systemic proinflammatory state related to insulin resistance and progression of osteosarcopenic obesity (15). The adipose tissue secretes proinflammatory cytokines associated with protein degradation, which will eventually lead to the development of obesity. Therefore, the evaluation of muscle health is suggested in individuals of all age groups.

Dietary protein sources and adequacy are known modifiable risk factors for SO prevalence (16, 17). It has been proposed that plant-based protein food sources, such as fresh fruits, vegetables, dried nuts, flax seeds, whole grains, and soybeans, have the beneficial effects of improving body composition (18), lipid metabolism (19), and cardiovascular health (20). In contrast, red meat-based diets are reported to have detrimental cardiometabolic effects on adults (21). It is necessary to prevent these negative effects on muscle health caused by CVDs and comorbidities associated with incongruities between body fat and muscle mass. Therefore, we investigated the association between dietary protein sources (and their adequacy) and the prevalence of SO in South Korean populations, according to weight status.

Methods

Study Setting and Participants

Eligible participants were enrolled in the Korean Medicine Daejeon Citizen Cohort (KDCC) study between 2017 and 2019. KDCC is the first prospective ongoing cohort study that is based on traditional KM to examine established associations between chronic disease and lifestyle risk factors (8). We performed a cross-sectional survey in 1,967 of these study participants using the Korean Sasang constitutional diagnostic questionnaire (KS-15) to identify the KM type, and a general health-related questionnaire (supplied by KM). All data were handled by the web-based Korean Medicine Data Center (KDC) electronic data capture system of the Korean Institute of Oriental Medicine (KIOM). Ethical approval was obtained after the participants provided written informed consent. This study was approved by the Ethics Committee of the Korean Institute of Oriental Medicine (IRB No. I-1703/002–002, DJDSKH-17-BM-12). Height, weight, and body composition (skeletal muscle mass [SMM] and body fat mass (22)) were measured by bioelectrical impedance analysis using the measuring stations BSM 370 and InBody 770 (InBody, Seoul, South Korea). Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared (kg/m2). Handgrip strength (kg, on either or both hands) was assessed using a grip strength dynamometer (Takei 5401; Takei Scientific Instruments Co., Ltd, Niigata, Japan); the maximum reading of two trials was used.

Definition of Sarcopenic Obesity

SO is defined as the coexistence of excess adiposity and low muscle mass/function (23). The diagnosis of SO was performed in two steps: (1) The participants were screened to detect an elevated body mass index (BMI). Obesity was defined as a BMI ≥ 25 kg/m2 using BIA for both sexes (24). (2) Altered skeletal muscle functional parameters and body composition (reduced muscle mass [kg and %] and increased %BF) were used to establish a firm diagnosis of SO.

A handgrip strength value < 28.0 kg for males and < 18.0 kg for females or the lowest quintile of muscle strength among the study participants indicated low muscle strength (25).

The skeletal muscle mass index (SMI) was calculated as the sum of the appendicular skeletal muscle (ASM) divided by height squared (kg/m2) (25). ASM was calculated as a percentage of body weight using Janssen’s formula (ASM/weight (kg), %) and as one standard deviation below the sex-specific mean for the young reference group (male: 243, female: 438, aged 20–40 years) (26). The upper two quintiles of the total body fat percentage (%BF) using BIA for each sex were used. For females, %BF quintiles were Q1: 25.9, Q2: 29.3–32.7, Q3: 32.8–35.5, Q4: 35.6–38.8, and Q5: 38.9–51.5; for males, these values were Q1: 16.9, Q2: 20.3–23.6, Q3: 23.7–26.3, Q4: 26.4–30.1, and Q5: 30.2–41.3.

Then, we classified participants into the SO, obese (OB), sarcopenic (S), and normal groups.

Dietary Assessment

The dietary intake of the participants was assessed using a validated short-form food frequency questionnaire (8), which contains 34 food items with serving sizes. Daily food amounts in grams and frequency were calculated from the energy (kcal/day) and macronutrients (carbohydrate, fat, and protein) (g/day) intakes using a computer-aided nutritional analysis program (CAN Pro, Version 5.0, The Korean Nutrition Society, 2015). This program is based on the recommended nutritional intake from the Dietary Reference Intake for Koreans (Korean Nutrients Society, 2020). To evaluate the protein adequacy of the individual diet among the participants, dietary protein sources (g/day) were classified into beans and tofu, fish, beef and pork, and poultry and eggs based on the Korean Nutrient Database.

Covariates

The participants’ age, sex, lifestyle choices (i.e., smoking status, alcohol consumption, and physical activity level), KM type, and energy intake (kcal/day) were used as covariates in the statistical analysis. Various South Korean population-based studies have reported KM type to have a genetic predisposition for abdominal obesity, insulin resistance, metabolic syndrome and/or inflammatory status. Individual characteristics of the KM type, such as personality, physiological functions, and symptoms of the participants, were assessed using the KS-15 (27). The KS-15 is a well-validated, shortened version, and cost-effective screening instrument for assessing the KM type that adapts the BMI and age- and sex-specific weighted values for higher coincidence with clinical relevance (Cronbach a = 0.630) (27).As previously reported, cardiometabolic outcomes (12) and inflammatory status (13) were assessed according to the two different KM types (Taeeum vs. Non-Taeeum [Soeum or Soyang]) in South Korean adults. Age, and energy intake were classified as continuous variables, while sex (male vs. female), smoking (no vs. yes), drinking (no vs. yes), physical activity (insufficient vs. sufficient), and KM type (Taeeum vs. Non-Taeeum) were classified as categorical variables.

Statistical Analyses

Frequencies and percentages were used as categorical variables in the descriptive analyses. The chi-square (χ2) test was used to compare the general and health-related characteristics (sex, smoking, alcohol consumption, physical activity, and KM type) in the descriptive analysis (Table 1). All data on continuous variables related to body composition, sarcopenia (ASM, kg, kg/m2, and %), body fat mass (kg, %) and grip strength (kg) (Table 1), macronutrients (carbohydrates, fat, and protein) intake, and dietary protein sources (beans and tofu, fish, beef and pork, and poultry and eggs) are presented as means ± standard errors (Table 2). Multiple linear regression models were used to examine the association between dietary protein sources, body fat mass (kg, %), SMI (kg/m2), ASM (%) and grip strength (kg) (Table 3). To deal with missing data, multiple imputation was employed to provide unbiased valid estimates of associations based on information from the available data. Multivariate logistic regression was used to evaluate the association between different protein sources (g/day) and the prevalence of sarcopenia or SO, according to the sarcopenia and obesity statuses. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) were also estimated after adjusting for age, sex, energy intake (kcal), smoking, alcohol consumption, physical activity, and KM type (Table 4). The relationship between dietary protein sources (A. beans and tofu; B. poultry and eggs) and total sarcopenia prevalence was also estimated through multivariate logistic regression based on the protein intake adequacy of the participants (Fig. 1). All analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA). All statistical tests were two-tailed, and p-values < 0.05 indicated statistical significance.

Results

A total of 1,967 participants with ages ranging from 30 to 55 years (average age 43.7 ± 0.2 years) were included, and 69.5% (n = 1,387) of the participants were female individuals. Higher prevalence of SO or sarcopenia was observed in female participants (SO; [N = 133, 66.8%], S; [N = 281, 83.1%]). Regarding the KM type, a higher ratio of Taeeum was observed in the SO (N = 173, 86.9%) and OB (N = 566, 91.7%) groups (p < 0.0001). Regarding health-related behaviors, more individuals who smoked and consumed alcohol were observed in the OB group (p < 0.0001). Inadequate physical activity was observed in the SO and S groups (p < 0.0001). Body composition statistics showed that body fat mass (male: 28.43 ± 0.61%; female: 39.95 ± 0.36%) was significantly higher in the SO and OB groups than in the other groups (p < 0.001). However, weight adjusted ASM (%) among individuals of both sexes was the lowest in the SO (male: 40.30 ± 0.36%; female: 32.47 ± 0.20%) and OB (male: 40.74 ± 0.17%; female: 32.90 ± 0.13%) groups than in the other groups (p < 0.0001) (Table 1).

 

Table 2 shows the daily energy (kcal/day), macronutrients, and dietary protein sources (g/day) consumed by participants according to their sarcopenia and obesity statuses. Compared with those in the other groups, lower energy intake was observed in male individuals in the SO group (p = 0.025). No significant differences were observed in the daily macronutrient intake of the participants (both sexes) among the groups. However, protein per kilogram of body weight (g/kg) was the lowest in the SO and OB groups (SO: 1.05 ± 0.02 and OB: 1.00 ± 0.01) than in the other groups (S: 1.28 ± 0.01 and normal: 1.22 ± 0.01) (p < 0.0001) (Table 2).

The association between dietary protein sources and body composition of the participants according to their sarcopenia and obesity statuses is presented in Table 3. There was no association between beans and tofu, poultry and eggs (g/day), and fish intakes and body composition (SMI, ASM, BFM, and PBF) among the participants. The consumption of beef and pork was positively associated with BFM (kg: beta = 0.003, p < 0.01), PBF (%: beta = 0.003, p < 0.01), and weight-adjusted ASM (%: beta=-0.002, p < 0.05) in the normal group (Table 3).

The number of participants with SO (n = 199) and sarcopenia (n = 338) is presented in Table 4. Multivariate logistic regression was performed by adjusting for covariates, including age, sex, energy intake (kcal), smoking, alcohol consumption, PA, and KM type (Table 4). No significant association was observed between dietary protein sources and SO or sarcopenia prevalence in the participants (Table 4).

Regarding the consumption of beans and tofu (g/day) and adequacy of protein intake, the lowest (Q1: 5.7 g/ day) quintiles showed a 2.5-fold increase in the risk of SO prevalence (AORs: 2.51, CI: 1.07–8.80), compared with the highest quintile (Q5: 60.1 g/day) in the excessive protein intake groups. Similarly, the lowest (Q1: 18.5 g/ day) quintiles of poultry and eggs intake showed a great increase in SO prevalence (AORs: 3.40, CI: 1.08–10.73) in the excessive protein intake groups, compared with the highest quintile (Q5: 137.5 g/day) (Fig. 1).

 

Discussion

We examined the relationship between dietary protein sources and protein adequacy, body composition, and prevalence of SO according to weight status in South Korean populations. It was found that lower consumption of plant-based protein foods, such as beans and tofu, or poultry and egg consumption among people who consumed excess daily dietary protein was strongly associated with SO prevalence. A positive association was observed between poultry and egg consumption and muscle strength in the sarcopenia group. Furthermore, red meat consumption showed a negative effect on imbalanced body composition by increased fat mass (kg and %) and decreased ASM (%) in participants with normal weight.

Obesity Risk Factors in Sarcopenic Obesity Prevalence

Our results are consistent with those of other studies on sarcopenia in the South Korean population (28, 29), using the weight-adjusted ASM to identify the prevalence of SO. Obesity is a low chronic inflammation factor that may lead to the development of SO by the infiltration of lipid deposition in the muscle tissue from extensive fat accumulation (30). In line with this, the combination of sarcopenia and obesity more significantly accelerates deteriorating muscle health when compared with the entities associated with chronic disease states in South Korean adults (31). Similarly, our results showed higher risks of body composition changes and prevalence of SO in the OB group.

From the perspective of muscle physiology, sarcopenia is independently associated with physical dysfunction and disability (32). We observed that higher physical inactivity reduced muscle function and mass, whereas it increased fat accumulation in the SO and sarcopenia groups. Currently, the coronavirus disease 2019 (COVID-19) pandemic has served as a potential risk factor for the onset of sarcopenia by interrupting physical activity, dietary habits, and sleep patterns in thousands of people who have been isolated, with excess time spent at home and owing to social distancing (33). Sarcopenia can lead to acute body composition changes, mitochondrial dysfunction, and insulin resistance, and may also increase the risk of COVID-19 infection and severity of symptoms.

A previous study reported decreased lean body mass and increased fat mass in the overweight/obese group, compared with healthy lean controls (34). There were positive associations with intermuscular fat mass and high sensitivity C-reactive protein (hs-CRP) and cortisol concentrations, as well as a negative association with SMM (34). Similarly, the SO and OB groups included more Taeeum-type individuals with predisposing metabolic risk factors (12, 13), compared with the BMI < 25 kg/m2 group. Our cross-sectional results from a previous cohort study showed associations with a higher prevalence of pre-MetS and higher hs-CRP levels in Taeeum-type South Korean populations (12, 13). This reflects obesity-related physiological characteristics associated with the Taeeum-type, which can be positively associated with SO prevalence in people who are overweight and obese. Contributing lifestyle factors include the consumption of uncontrolled or western-type diet and physical inactivity or sedentary lifestyle, which lead to imbalanced inflammatory mediators stimulating muscle tissues that aggravate low-grade inflammation (35).

Effects of Dietary Protein Sources and Adequacy on Muscle Physiology and Body Composition

Dietary protein ingestion is a key modulator of muscle mass and function (36). We found that the consumption of poultry and eggs positively affected grip strength (kg) in the sarcopenia group, while fat mass percentage increased with meat intake (g/d), whereas ASM (%) decreased in the normal group. It could be argued that the energy balance and protein adequacy might be problematic dietary risk factors in the participants who already had excess intake of energy (S [male: 2303.51 ± 46.86, female: 2072.89 ± 27.95] and normal [male: 2303.51 ± 46.86, female: 2072.89 ± 27.95], kcal/day) and protein (S: 1.28 ± 0.01 and normal: 1.22 ± 0.01, g/kg) compared with their dietary reference intake.

In a previous study, we found an approximately 2-fold higher meat intake increase in people with SO (PR: 1.93, 95% CI: 1.07–3.50), compared with that of the lowest tertile in older South Koreans with cardio-metabolic diseases (37). Consistent with these findings, our results showed that, participants who consumed < 18.5 g/day of poultry and eggs in the excessive protein intake individuals (> 1.2 g/kg/day) showed 3.4 times higher risk of developing SO compared with those in the highest intake group (Q5: 137.5 g/day). Similarly, with beans and tofu consumption, there was a 2.5-fold higher risk of developing sarcopenia in participants who had < 5.7 g/day intake in the excessive protein intake individuals.

In muscle protein synthesis, leucine is the major contributor to postprandial muscle anabolic synthesis (38). Compared with animal proteins, plant-based proteins have low leucine content, which may affect the anabolic properties (39). Nevertheless, plant-based proteins have various health-related benefits, including decreased BMI, reduced body fat, decreased caloric intake, increased energy expenditure, reduced insulin resistance, and prevention of obesity, T2DM, and CVDs (40). Cardiometabolic diseases often coexist with chronic inflammation and obesity, which are linked to poor diet quality and excess body weight. Therefore, an adequate amount of high-quality protein and supplementation with more plant-derived foods, such as legumes and beans, and low-saturated fat diet, could reduce the risk of underlying health conditions.

Nutritional Recommendations for Populations with Sarcopenic Obesity to Improve Clinical and Nutritional Statuses

Plant-based diets have been recommended to prevent chronic diseases by the Joint Food and Agriculture Organization of the United Nations and World Health Organization expert consultations since 2004 (41). In the EPIC-Oxford cohort study, individuals who were vegetarian or vegan and had a higher intake of fiber and polyunsaturated fatty acid and a lower intake of saturated fatty acid (SFA) had a decreased risk of ischemic heart disease, compared with meat-eaters (42).

A balanced diet is recommended, with anti-inflammatory effects derived from the consumption of plentiful vegetables and fruits, as well as the moderating effects of whole grains, low-fat dairy products, fish, legumes, and poultry and eggs consumption while avoiding SFAs found in sugars and snacks. Finally, individuals who have metabolic high-risk factors, such as obesity, insulin resistance, and metabolic syndrome, should have a healthy diet to improve their health. Moreover, having a healthy and active lifestyle is necessary for achieving weight control and lowering the glucose levels and lipid level parameters in people with obesity.

Strength and Limitations

To the best of our knowledge, this is the first study to evaluate the associations between SO prevalence and dietary protein sources by considering the predominant personality type with complex and different lifestyles, including diet, using the KM type. We also used valid and reliable nationally-representative, multilayer sampling data from the KDCC study. Finally, a wide range of covariates were considered in the adjustment of the multivariate analyses, including age, sex, health-related behaviors (smoking status, alcohol consumption, and physical activity level), KM type, and energy intake (kcal/day). These methods yielded descriptive results which greatly enhanced our understanding of SO prevalence and risk factors.

This study has some limitations. First, this cross-sectional study cannot provide causal inferences due to the limited evidence. Second, we did not consider the residual confounding factors, such as genetic or medical history, as covariates. Lastly, reverse causality might exist because the individuals with SO tended to consume lesser protein sources than their counterparts. In particular, lower energy intake was described in male participants with SO than in male participants of in the normal group. However, there was no variation in dietary intake between groups according to the status of sarcopenia and obesity in the participants; however, protein (g/kg) consumption of the participants varied between groups. The reason could be that people with higher BMI values did not consume adequate and/or high-quality protein relative to their body weight. It is also predicted that they consumed higher percentages of fat- or carbohydrate-rich foods in their diet. Therefore, careful interpretation is required to ensure the generalizability of our findings.

Conclusions

In conclusion, dietary protein sources and adequacy are crucial modulators of muscle quality in South Korean populations. Therefore, optimal dietary choices and adequate nutritional support are essential to maintain muscle health in people who follow an obesogenic lifestyle with an unhealthy diet.

Abbreviations

ASM

appendicular skeletal muscle

BFM

body fat mass

SMI

skeletal muscle mass index

SO

sarcopenic obesity

PBF

percent body fat

SMM

skeletal muscle mass

Declarations

Ethics approval and consent to participate

The study was approved by the Ethics Committee of the Korean Institute of Oriental Medicine (IRB No. I-1703/002-002, DJDSKH-17-BM-12). Written informed consent was obtained from all participants prior to data collection.

Consent for publication

Not applicable

Data andmaterials

The datasets are not available due to confidentiality and ethical concerns. Further inquiries can be directed to the corresponding author.

Competing Interests

The authors have no competing interests to declare.

Funding

This work was supported by the Korea Institute of Oriental Medicine (Grant number KSN2023120).

Authors’ contributions and Acknowledgments

Statement of authors’ contributions to manuscript:Conceptualization: J.K.; Data curation& resources: K.J. and S.L.a; Analysis and interpretation of data: J.K. and Y.B.; Original manuscript: J.K.; Review and editing: Y.B. and S.L.b; Funding acquisition and project administration: S.L. b

References

  1. Prado CMM, Wells JCK, Smith SR, Stephan BCM, Siervo M. Sarcopenic obesity: A Critical appraisal of the current evidence. Clin Nutr. 2012;31(5):583–601. doi: https://doi.org/10.1016/j.clnu.2012.06.010.
  2. Silveira EA, da Silva Filho RR, Spexoto MCB, Haghighatdoost F, Sarrafzadegan N, de Oliveira C. The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications. Int J Mol Sci. 2021;22(9):4339. Epub 2021/05/01. doi: 10.3390/ijms22094339. PubMed PMID: 33919368; PubMed Central PMCID: PMCPMC8122649.
  3. Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc. 2015;74(4):405–12. Epub 2015/04/27. doi: 10.1017/S002966511500169X.
  4. Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Perez-Zepeda MU, Cesari M. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging. 2013;17(3):259–62. doi: 10.1007/s12603-012-0434-0.
  5. Stenholm S, Harris TB, Rantanen T, Visser M, Kritchevsky SB, Ferrucci L. Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care. 2008;11(6):693–700. doi: 10.1097/MCO.0b013e328312c37d. PubMed PMID: 00075197-200811000-00004.
  6. Cantero I, Abete I, Babio N, Arós F, Corella D, Estruch R, et al. Dietary Inflammatory Index and liver status in subjects with different adiposity levels within the PREDIMED trial. Clin Nutr. 2018;37(5):1736–43.
  7. Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18(1):5. doi: 10.1186/s12916-019-1474-7.
  8. Baek Y, Seo B-N, Jeong K, Yoo H, Lee S. Lifestyle, genomic types and non-communicable diseases in Korea: a protocol for the Korean Medicine Daejeon Citizen Cohort study (KDCC). BMJ Open. 2020;10(4):e034499. doi: 10.1136/bmjopen-2019-034499.
  9. Jang E, Baek Y, Park K, Lee S. Could the Sasang constitution itself be a risk factor of abdominal obesity? BMC Complement Altern Med. 2013;13(1):72. doi: 10.1186/1472-6882-13-72.
  10. Choi K, Lee J, Yoo J, Lee E, Koh B, Lee J. Sasang constitutional types can act as a risk factor for insulin resistance. Diabetes Res Clin Pract. 2011;91(3):e57-60. Epub 2010/12/15. doi: 10.1016/j.diabres.2010.11.017. PubMed PMID: 21146241.
  11. Kim JY, Lee, Si-Woo, and Baek, Young-Hwa.,. Effects of Life Style on Metabolic Syndrome Stage according to the Sasang Constitution. J Sasang Const Med. 2017;29(3):232–41. doi: 10.7730/JSCM.2017.29.3.232.
  12. Kim J, Jeong K, Lee S, Seo B-N, Baek Y. Low nutritional status links to the prevalence of pre-metabolic syndrome and its cluster in metabolically high-risk Korean adults: A cross-sectional study. Medicine. 2021;100(20):e25905. doi: 10.1097/md.0000000000025905. PubMed PMID: 00005792-202105210-00039.
  13. Kim J, Jeong K, Lee S, Baek Y. Relationship between Low Vegetable Consumption, Increased High-Sensitive C-Reactive Protein Level, and Cardiometabolic Risk in Korean Adults with Tae-Eumin: A Cross-Sectional Study. Evid Based Complement Alternat Med. 2021;2021:3631445. doi: 10.1155/2021/3631445.
  14. Andreoli A, Garaci F, Cafarelli FP, Guglielmi G. Body composition in clinical practice. Eur J Radiol. 2016;85(8):1461–8. doi: https://doi.org/10.1016/j.ejrad.2016.02.005.
  15. Stefanaki C, Pervanidou P, Boschiero D, Chrousos GP. Chronic stress and body composition disorders: implications for health and disease. Hormones. 2018;17(1):33–43. doi: 10.1007/s42000-018-0023-7.
  16. Bauer J, Biolo G, Cederholm T, Cesari M, Cruz-Jentoft AJ, Morley JE, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542–59.
  17. Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33(6):929–36.
  18. Haghighat N, Ashtary-Larky D, Bagheri R, Wong A, Cheraghloo N, Moradpour G, et al. Effects of 6 Months of Soy-Enriched High Protein Compared to Eucaloric Low Protein Snack Replacement on Appetite, Dietary Intake, and Body Composition in Normal-Weight Obese Women: A Randomized Controlled Trial. Nutrients. 2021;13(7):2266. PubMed PMID: doi:10.3390/nu13072266.
  19. Kim I-S. Current perspectives on the beneficial effects of soybean isoflavones and their metabolites for humans. Antioxidants. 2021;10(7):1064.
  20. Islam SU, Ahmed MB, Ahsan H, Lee Y-S. Recent Molecular Mechanisms and Beneficial Effects of Phytochemicals and Plant-Based Whole Foods in Reducing LDL-C and Preventing Cardiovascular Disease. Antioxidants. 2021;10(5):784. PubMed PMID: doi:10.3390/antiox10050784.
  21. Norde MM, Collese TS, Giovannucci E, Rogero MM. A posteriori dietary patterns and their association with systemic low-grade inflammation in adults: A systematic review and meta-analysis. Nutr Rev. 2021;79(3):331–50.
  22. Yorke AM, Curtis AB, Shoemaker M, Vangsnes E. Grip strength values stratified by age, gender, and chronic disease status in adults aged 50 years and older. J Geriatr Phys Ther. 2015;38(3):115–21. Epub 2015/01/17. doi: 10.1519/jpt.0000000000000037. PubMed PMID: 25594523.
  23. Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W, et al. Prevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes: The Korean Sarcopenic Obesity Study (KSOS). Diabetes Care. 2010;33(7):1497–9. doi: 10.2337/dc09-2310.
  24. Organization WH. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.
  25. Chen L-K, Woo J, Assantachai P, Auyeung T-W, Chou M-Y, Iijima K, et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020;21(3):300-7.e2. doi: https://doi.org/10.1016/j.jamda.2019.12.012.
  26. Studenski SA, Peters KW, Alley DE, Cawthon PM, McLean RR, Harris TB, et al. The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates. J Gerontol A Biol Sci Med Sci. 2014;69(5):547 – 58. doi: 10.1093/gerona/glu010.
  27. Baek Y-H, Jang E-S, Park K-H, Yoo J-H, Jin H-J, Lee S-W. Development and validation of brief KS-15 (Korea Sasang constitutional diagnostic questionnaire) based on body shape, temperament and symptoms. J Sasang Const Med. 2015;27(2):211–21.
  28. Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, et al. Sarcopenic Obesity: Prevalence and Association With Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care. 2010;33(7):1652–4. doi: 10.2337/dc10-0107.
  29. Kim Y-S, Lee Y, Chung Y-S, Lee D-J, Joo N-S, Hong D, et al. Prevalence of Sarcopenia and Sarcopenic Obesity in the Korean Population Based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci. 2012;67(10):1107–13. doi: 10.1093/gerona/gls071.
  30. Sakuma K, Yamaguchi A. Sarcopenic obesity and endocrinal adaptation with age. Int J Endocrinol. 2013;2013:204164-. Epub 2013/04/11. doi: 10.1155/2013/204164. PubMed PMID: 23690769.
  31. An KO, Kim J. Association of Sarcopenia and Obesity With Multimorbidity in Korean Adults: A Nationwide Cross-Sectional Study. J Am Med Dir Assoc 2016;17(10):960.e1-.e7. doi: https://doi.org/10.1016/j.jamda.2016.07.005.
  32. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age and Ageing. 2010;39(4):412–23. doi: 10.1093/ageing/afq034.
  33. Kirwan R, McCullough D, Butler T, Perez de Heredia F, Davies IG, Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. GeroScience. 2020;42(6):1547–78. doi: 10.1007/s11357-020-00272-3.
  34. Stefanaki C, Peppa M, Boschiero D, Chrousos GP. Healthy overweight/obese youth: early osteosarcopenic obesity features. European journal of clinical investigation. 2016;46(9):767–78.
  35. Rogeri PS, Zanella R, Jr., Martins GL, Garcia MDA, Leite G, Lugaresi R, et al. Strategies to Prevent Sarcopenia in the Aging Process: Role of Protein Intake and Exercise. Nutrients. 2021;14(1). Epub 2022/01/12. doi: 10.3390/nu14010052. PubMed PMID: 35010928; PubMed Central PMCID: PMCPMC8746908.
  36. Kalyani RR, Corriere M, Ferrucci L. Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2(10):819–29. Epub 2014/03/06. doi: 10.1016/S2213-8587(14)70034-8. PubMed PMID: 24731660.
  37. Kim J, Baek Y, Jeong K, Lee S. Association of Dietary Factors With Grip Strength, Body Fat, and Prevalence of Sarcopenic Obesity in Rural Korean Elderly With Cardiometabolic Multimorbidity. Front Nutr. 2022;9. doi: 10.3389/fnut.2022.910481.
  38. Devries MC, McGlory C, Bolster DR, Kamil A, Rahn M, Harkness L, et al. Protein leucine content is a determinant of shorter-and longer-term muscle protein synthetic responses at rest and following resistance exercise in healthy older women: a randomized, controlled trial. Am J Clin Nutr. 2018;107(2):217–26.
  39. van Vliet S, Burd NA, van Loon LJ. The Skeletal Muscle Anabolic Response to Plant- versus Animal-Based Protein Consumption. J Nutr. 2015;145(9):1981–91. Epub 2015/08/01. doi: 10.3945/jn.114.204305. PubMed PMID: 26224750.
  40. Mullins AP, Arjmandi BH. Health Benefits of Plant-Based Nutrition: Focus on Beans in Cardiometabolic Diseases. Nutrients. 2021;13(2):519. PubMed PMID: doi:10.3390/nu13020519.
  41. Organization WH. Vitamin and mineral requirements in human nutrition: World Health Organization; 2004.
  42. Sobiecki JG, Appleby PN, Bradbury KE, Key TJ. High compliance with dietary recommendations in a cohort of meat eaters, fish eaters, vegetarians, and vegans: results from the European Prospective Investigation into Cancer and Nutrition–Oxford study. Nutr Res. 2016;36(5):464–77. doi: https://doi.org/10.1016/j.nutres.2015.12.016.

Tables

Table 1

General characteristics, body composition and grip strength of the participants according to the status of sarcopenia and obesity.

General characteristics

SO (n = 199)

OB (n = 617)

S (n = 338)

Normal (n = 813)

p-value

Age (years) (mean ± SE)

               

< 0.001

30–40 years (n, %)

47

(23.6)

222

(36.0)

103

(30.5)

304

(37.4)

 

41–55 years

152

(76.4)

395

(64.0)

235

(69.5)

509

(62.6)

 

Sex (%)

               

< 0.0001

Male

66

(33.2)

285

(46.2)

57

(16.9)

195

(24.0)

 

Female

133

(66.8)

332

(53.8)

281

(83.1)

618

(76.0)

 

KM type1 (%)

               

< 0.0001

Taeeum

173

(86.9)

566

(91.7)

75

(22.2)

186

(22.9)

 

Soeum

2

(1.0)

4

(0.7)

130

(38.5)

253

(31.1)

 

Soyang

24

(12.4)

47

(7.6)

133

(39.4)

374

(46.0)

 

Smoking (%)

               

< 0.0001

No

149

(74.9)

445

(72.1)

300

(88.8)

670

(82.4)

 

Yes

50

(25.1)

172

(27.9)

38

(11.2)

143

(17.6)

 

Drinking (%)

               

< 0.001

No

87

(43.7)

206

(33.4)

155

(45.9)

338

(41.6)

 

Yes

112

(56.3)

411

(66.6)

183

(54.1)

475

(58.4)

 

Physical activity2 (%)

               

< 0.05

Insufficient

144

(72.3)

404

(65.5)

245

(72.5)

536

(65.9)

 

Sufficient

55

(27.6)

213

(34.5)

93

(27.5)

277

(34.1)

 

Body composition

                 

SMI, kg/m2

                 

Male

10.90

± 0.09b

11.31

± 0.05a

9.96

± 0.10c

10.17

± 0.06c

< 0.0001

Female

8.73

± 0.06b

9.07

± 0.04a

7.87

± 0.04d

8.10

± 0.03c

< 0.0001

ASM, %

                 

Male

40.30

± 0.36d

40.74

± 0.17c

43.78

± 0.38b

44.47

± 0.21a

< 0.0001

Female

32.47

± 0.20c

32.90

± 0.13c

36.36

± 0.14b

37.22

± 0.09a

< 0.0001

Body fat mass, kg

                 

Male

22.39

± 0.67a

23.35

± 0.31a

14.55

± 0.70b

14.39

± 0.38b

< 0.0001

Female

26.53

± 0.37b

27.73

± 0.24a

17.31

± 0.26c

17.20

± 0.17c

< 0.0001

Body fat mass, %

                 

Male

28.43

± 0.61a

27.96

± 0.29a

21.82

± 0.65b

20.87

± 0.35b

< 0.0001

Female

39.95

± 0.36a

39.53

± 0.23a

31.96

± 0.25b

30.83

± 0.17c

< 0.0001

Body mass index, kg/m

27.14

± 0.16b

27.81

± 0.09a

22.11

± 0.13c

22.25

± 0.08d

< 0.0001

Grip strength, kg

                 

Male

30.97

± 0.61b

41.69

± 0.29a

29.40

± 0.65b

40.50

± 0.35a

< 0.0001

Female

17.78

± 0.27b

24.26

± 0.17a

17.54

± 0.18b

23.98

± 0.12a

< 0.0001

The status of sarcopenia and obesity was defined by muscle strength (kg), body composition (reduced muscle mass (kg and %) and increased %BF) after screening for elevated body mass index (BMI) of the participants.
a The different letters indicate statistically significant differences (p < 0.05), analyzed using ANCOVA followed by Bonferroni’s multiple comparison test.
§ The least-square is presented as means ± SEs adjusted for age and sex (age only adjusted for body composition).
1 KM (Korean medicine) type was categorized into three groups: Taeeum, Soeum, and Soyang
2 Physical activity (total MET minutes per week): insufficient (< 600 MET-min/week) and sufficient (≥ 600 MET-min/week).
SMI: skeletal muscle index, ASM: appendicular skeletal muscle

Table 2

Group differences in dietary intake according to the status of sarcopenia and obesity among the participants.

Dietary intake and protein sources

SO (n = 199)

OB (n = 617)

 

S (n = 338)

Normal (n = 813)

p-value

Energy intake (kcal/day)1

                   

Male

2071.70

± 81.35b

2238.34

± 38.89a

 

2406.19

± 87.02a

2303.51

± 46.86a

0.025

Female

2112.53

± 60.41

2099.36

± 38.09

 

2010.15

± 41.38

2072.89

± 27.95

0.364

Macronutrients (g/day)

                   

Carbohydrates (g)

320.00

± 3.00

317.13

± 1.73

 

321.35

± 2.31

319.48

± 1.49

0.504

Fat (g)

52.17

± 0.99

53.78

± 0.57

 

53.15

± 0.76

52.59

± 0.49

0.351

Protein (g)

71.37

± 0.73

72.20

± 0.42

 

72.11

0.56

71.26

± 0.36

0.312

Protein (g/kg)

1.05

± 0.02c

1.00

± 0.01c

 

1.28

± 0.01a

1.22

± 0.01b

< 0.0001

C : F: P (%)

59.6: 22.0: 13.4

59.8: 22.7: 13.5

 

60.9: 22.4: 13.5

60.2: 22.2: 13.4

N/S

Dietary protein sources (g/day)2

                   

Beans and tofu

26.07

± 2.09

29.29

± 1.20

 

27.64

± 1.62

28.32

± 1.03

0.578

Poultry and eggs

73.35

± 3.92

71.69

± 2.26

 

70.10

± 3.02

68.28

± 1.63

0.569

Beef and pork

102.07

± 7.23

107.89

± 4.16

 

113.30

± 5.59

109.43

± 3.58

0.663

Fish

13.63

± 1.28

13.72

± 0.74

 

15.20

± 0.99

14.26

± 0.63

0.655

1 Adjusted for age alone
2 The least-square is presented as means ± SEs adjusted for age, sex, and energy intake (kcal).
a The different letters indicate statistically significant differences (p < 0.05), analyzed using ANCOVA followed by Bonferroni’s multiple comparison test.

Table 3

Associations between dietary protein sources and the muscle function and body composition of the participants.

 

SO (n = 199)

OB (n = 617)

 

S (n = 338)

Normal (n = 813)

Protein sources (g/day)

beta

p

beta

p

 

beta

p

beta

p

Beans and tofu

                 

SMI, kg/m2

-0.001

0.52

0.000

0.81

 

0.001

0.29

0.000

0.80

ASM, %

-0.003

0.68

0.000

0.41

 

-0.005

0.36

-0.003

0.24

BFM, kg

0.003

0.77

-0.007

0.39

 

0.014

0.08

0.005

0.23

PBF, %

0.004

0.74

-0.005

0.42

 

0.011

0.23

0.005

0.27

HGS, kg

0.009

0.32

-0.004

0.48

 

0.008

0.28

0.000

0.99

Poultry and eggs

                 

SMI, kg/m2

0.002

0.08

0.001

0.37

 

0.000

0.91

0.000

0.50

ASM, %

0.005

0.09

0.003

0.10

 

-0.004

0.11

-0.002

0.19

BFM, kg

-0.003

0.53

-0.004

0.44

 

0.004

0.27

0.002

0.43

PBF, %

-0.007

0.15

-0.006

0.11

 

0.005

0.18

0.003

0.23

HGS, kg

0.003

0.40

0.001

0.70

 

0.007

0.04

-0.002

0.39

Beef and pork

                 

SMI, kg/m2

0.001

0.12

-0.001

0.76

 

0.000

0.61

-0.001

0.89

ASM, %

0.003

0.09

0.000

0.82

 

-0.002

0.14

-0.002

0.02

BFM, kg

-0.002

0.48

0.002

0.47

 

0.001

0.56

0.003

0.01

PBF, %

-0.004

0.13

0.001

0.74

 

0.006

0.20

0.003

0.01

HGS, kg

-0.001

0.57

0.000

0.89

 

-0.001

0.74

-0.001

0.62

Fish

                 

SMI, kg/m2

0.001

0.99

-0.004

0.05

 

0.000

0.42

0.000

0.99

ASM, %

-0.006

0.68

0.000

0.93

 

-0.001

0.11

-0.002

0.13

BFM, kg

-0.004

0.51

0.004

0.21

 

0.005

0.54

0.001

0.30

PBF, %

0.010

0.67

-0.003

0.80

 

0.021

0.14

0.011

0.13

HGS, kg

-0.022

0.25

-0.008

0.49

 

-0.003

0.78

-0.003

0.58

Adjusted for age, sex, energy intake (kcal), smoking, alcohol consumption, physical activity, and Korean Medicine type
Statistical significance was accepted at *P < 0.05.
BMI: body mass index, SMI: skeletal muscle index, ASM: appendicular skeletal muscle, BFM: body fat mass, PBF: percent body fat

Table 4

Multivariate logistic regression analysis of the association between different protein sources (g/day) and prevalence of SO and sarcopenia.

Dietary protein sources

Sarcopenic obesity (n = 199)

Sarcopenia (n = 338)

 

Beans and tofu

     

(ref, highest: 60.1 g/day)

ORs

 

intermediate: 17.0 g/day

1.60 (0.86–3.00)

1.04 (0.64–1.69)

 

lowest: 5.7 g/day

1.84 (0.96–3.54)

0.80 (0.78–1.34)

 

Poultry and eggs

     

(ref, highest: 137.5 g/day)

ORs

 

intermediate: 51.5 g/day

0.66 (0.40–1.11)

1.16 (0.78–1.74)

 

lowest: 18.5 g/day

1.11 (0.62–1.98)

0.67 (0.43–1.06)

 

Beef and pork

     

(ref, highest: 169.6 g/day)

ORs

 

intermediate: 44.6 g/day

1.31 (0.80–2.52)

0.84 (0.57–1.23)

 

lowest: 10.4 g/day

1.36 (0.74–2.52)

0.77 (0.47–1.27)

 

Fish

     

(ref, highest: 121.8 g/day)

ORs

 

intermediate: 17.0 g/day

0.93 (0.55–1.56)

0.86 (0.57–1.32)

 

lowest: 1.1 g/day

0.89 (0.53–1.51)

0.83 (0.54–1.23)

 

Age, sex, energy intake (kcal), smoking, drinking, physical activity, and Korean Medicine type were adjusted.